ArticleActa pharmaceutica Sinica. B2020

Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy.

Yuqin Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.